Jianqiang Cai

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center

发表论文 101 篇 · 总被引 5082 次 · h-index 27

代表论文

• Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) (2022 · Liver Cancer · 被引 111)
• Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements (2022 · Liver Cancer · 被引 70)
• APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 (2024 · Hepatology International · 被引 59)
• Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients (2022 · Clinical Cancer Research · 被引 56)
• Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma (2022 · Translational Cancer Research · 被引 34)
• Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases (2024 · Cancer Letters · 被引 13)